• Explore /
  • Poster
  • / Preoperative predictors of biochemical recurrence in a phase II trial of neoadjuvant therapy in very high-risk prostate cancer.

Preoperative predictors of biochemical recurrence in a phase II trial of neoadjuvant therapy in very high-risk prostate cancer.

Abstract Poster

Authors

null

Ashanda Rosetta Patrice Esdaille

University of Wisconsin Health, Madison, WI

Ashanda Rosetta Patrice Esdaille , Christos Kyriakopoulos , Steve Y. Cho , Brian Johnson , Glenn O. Allen , Wei Huang , Alejandro Roldán-Alzate , David J. Beebe , Hamid Emamekhoo , Shane Wells , Joshua Michael Lang , David Frazier Jarrard

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session: Prostate Cancer - Advanced Disease

Track

Prostate Cancer - Advanced

Sub Track

Symptoms, Toxicities, and Whole-Person Care

Citation

J Clin Oncol 39, 2021 (suppl 6; abstr 74)

DOI

10.1200/JCO.2021.39.6_suppl.74

Abstract #

74

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

Poster

2024 ASCO Genitourinary Cancers Symposium

Phase II study of pembrolizumab in combination with radiation with or without olaparib in localized high-risk prostate cancer.

Phase II study of pembrolizumab in combination with radiation with or without olaparib in localized high-risk prostate cancer.

First Author: Zin Myint

First Author: Rana R. McKay

First Author: Yao Zhu

First Author: Arun Azad